Envestnet Asset Management
GBIO

Envestnet Asset Management’s Generation Bio GBIO Stock Holding History

Envestnet Asset Management’s Portfolio GBIO Stock Details GBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,410
Closed -$14.9K – 4392
2024
Q4 		$14.9K Buy
+1,410
New +$25.1K ﹤0.01% 4292
2024
Q1 		– Sell
-1,792
Closed -$29.6K – 4219
2023
Q4 		$29.6K Buy
+1,792
New +$31.2K ﹤0.01% 4009

Other funds holding GBIO

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Envestnet Asset Management's GBIO Position: Q1 2025 in Review

Envestnet Asset Management sold out of Generation Bio (GBIO) in Q1 2025, closing a stake of 1,410 shares — an estimated $14.9K sold.

Envestnet Asset Management first reported a position in GBIO in Q4 2023 and held it in 2 quarters. The position peaked at $29.6K in Q4 2023. 79 funds tracked by Wall St. Rank hold GBIO as of Q1 2025.

  • Envestnet Asset Management reported no remaining Generation Bio position as of Q1 2025 after selling out during the quarter.
  • Envestnet Asset Management sold 1,410 Generation Bio shares in Q1 2025, an estimated $14.9K.
  • Envestnet Asset Management first reported a position in Generation Bio in Q4 2023 and held it in 2 quarters.
  • Envestnet Asset Management's Generation Bio position peaked at $29.6K in Q4 2023.
  • 79 funds tracked by Wall St. Rank held Generation Bio as of Q1 2025.

Based on Envestnet Asset Management's 13F filing for Q1 2025, filed 29 Apr 2025.